Brevan Howard Capital Management LP Sana Biotechnology, Inc. Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 140,707 shares of SANA stock, worth $236,387. This represents 0.0% of its overall portfolio holdings.
Number of Shares
140,707
Previous 73,626
91.11%
Holding current value
$236,387
Previous $120,000
96.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SANA
# of Institutions
171Shares Held
115MCall Options Held
337KPut Options Held
337K-
Flagship Pioneering Inc. Cambridge, MA25MShares$42 Million17.82% of portfolio
-
Black Rock Inc. New York, NY11MShares$18.6 Million0.0% of portfolio
-
Baillie Gifford & CO10.2MShares$17.1 Million0.02% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$17.1 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.87MShares$13.2 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $320M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...